Ellen Carl

3.0k total citations
81 papers, 2.3k citations indexed

About

Ellen Carl is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Ellen Carl has authored 81 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pathology and Forensic Medicine, 30 papers in Neurology and 12 papers in Molecular Biology. Recurrent topics in Ellen Carl's work include Multiple Sclerosis Research Studies (39 papers), Cerebral Venous Sinus Thrombosis (23 papers) and Systemic Lupus Erythematosus Research (11 papers). Ellen Carl is often cited by papers focused on Multiple Sclerosis Research Studies (39 papers), Cerebral Venous Sinus Thrombosis (23 papers) and Systemic Lupus Erythematosus Research (11 papers). Ellen Carl collaborates with scholars based in United States, Italy and United Kingdom. Ellen Carl's co-authors include Robert Zivadinov, Bianca Weinstock‐Guttman, Niels Bergsland, Michael G. Dwyer, Jesper Hagemeier, Cheryl Kennedy, Murali Ramanathan, Deepa P. Ramasamy, David Hojnacki and Jacqueline Durfee and has published in prestigious journals such as PLoS ONE, NeuroImage and Neurology.

In The Last Decade

Ellen Carl

80 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ellen Carl United States	28	1.3k	927	394	340	317	81	2.3k
Jesper Hagemeier United States	35	2.0k 1.6×	993 1.1×	776 2.0×	502 1.5×	553 1.7×	109	3.2k
Vallabh Janardhan United States	22	1.2k 0.9×	1.3k 1.4×	215 0.5×	335 1.0×	223 0.7×	47	3.2k
Deepa P. Ramasamy United States	34	2.1k 1.7×	938 1.0×	622 1.6×	562 1.7×	322 1.0×	107	3.0k
Emilia Sbardella Italy	33	912 0.7×	447 0.5×	473 1.2×	206 0.6×	440 1.4×	101	3.0k
Clare L. Fraser Australia	29	651 0.5×	846 0.9×	282 0.7×	336 1.0×	569 1.8×	142	2.7k
Ilaria Bartolomei Italy	24	436 0.3×	1.5k 1.6×	117 0.3×	140 0.4×	340 1.1×	39	2.2k
Z. Harry Rappaport Israel	31	854 0.7×	1.5k 1.6×	126 0.3×	132 0.4×	210 0.7×	104	3.2k
Saburo Sakaki Japan	31	317 0.2×	1.1k 1.2×	179 0.5×	199 0.6×	507 1.6×	114	2.8k
G D Perkin United Kingdom	20	504 0.4×	1.4k 1.5×	208 0.5×	142 0.4×	221 0.7×	63	2.5k
Sasha Gulati Norway	32	774 0.6×	631 0.7×	290 0.7×	80 0.2×	129 0.4×	124	2.6k

Countries citing papers authored by Ellen Carl

Since Specialization

Citations

This map shows the geographic impact of Ellen Carl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Carl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Carl more than expected).

Fields of papers citing papers by Ellen Carl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Carl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Carl. The network helps show where Ellen Carl may publish in the future.

Co-authorship network of co-authors of Ellen Carl

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Carl. A scholar is included among the top collaborators of Ellen Carl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Carl. Ellen Carl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carl, Ellen, Martin C. Mahoney, Colleen A. Hanlon, et al.. (2022). Transcranial Magnetic Stimulation for Long-Term Smoking Cessation: Preliminary Examination of Delay Discounting as a Therapeutic Target and the Effects of Intensity and Duration. Frontiers in Human Neuroscience. 16. 920383–920383. 8 indexed citations

Bergsland, Niels, Michael G. Dwyer, Jesper Hagemeier, et al.. (2019). Aging and Brain Atrophy in Multiple Sclerosis. Journal of Neuroimaging. 29(4). 527–535. 39 indexed citations

Kim, Soo-Hyun, Lawrence Chang, Bianca Weinstock‐Guttman, et al.. (2018). Complementary and Alternative Medicine Usage by Multiple Sclerosis Patients: Results from a Prospective Clinical Study. The Journal of Alternative and Complementary Medicine. 24(6). 596–602. 33 indexed citations

Bergsland, Niels, Michael G. Dwyer, Jesper Hagemeier, et al.. (2018). Brain Atrophy Is Associated with Disability Progression in Patients with MS followed in a Clinical Routine. American Journal of Neuroradiology. 39(12). 2237–2242. 40 indexed citations

Zivadinov, Robert, Jennie Medin, Nasreen Khan, et al.. (2018). Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study. Multiple Sclerosis and Related Disorders. 27. 65–73. 5 indexed citations

Zivadinov, Robert, Niels Bergsland, Jesper Hagemeier, et al.. (2018). Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study. Journal of the Neurological Sciences. 387. 152–156. 5 indexed citations

Zivadinov, Robert, et al.. (2017). Evaluating the Effect of Teriflunomide on Cortical Gray Matter Atrophy in the Phase 3 TOPIC Study (P6.334). Neurology. 88(16_supplement). 2 indexed citations

Zivadinov, Robert, David Hojnacki, Niels Bergsland, et al.. (2016). Effect of natalizumab on brain atrophy and disability progression in multiple sclerosis patients over 5 years. European Journal of Neurology. 23(6). 1101–1109. 15 indexed citations

Weinstock‐Guttman, Bianca, Jesper Hagemeier, Katelyn Kavak, et al.. (2016). Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation. Journal of Neurology Neurosurgery & Psychiatry. 87(9). 937–943. 14 indexed citations

10.

Zivadinov, Robert, Michael G. Dwyer, Niels Bergsland, et al.. (2015). MRI indicators of brain tissue loss: 3-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study in relapsing-remitting multiple sclerosis (P7.255). Neurology. 84(14_supplement). 1 indexed citations

11.

Zivadinov, Robert, Dana Horáková, Niels Bergsland, et al.. (2014). Humoral responses to herpesviruses are associated with neurodegeneration after a demyelinating event: Results from the Multi-Center SET study. Journal of Neuroimmunology. 273(1-2). 58–64. 22 indexed citations

12.

Bergsland, Niels, Bianca Weinstock‐Guttman, Cheryl Kennedy, et al.. (2014). Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome. Journal of the Neurological Sciences. 338(1-2). 128–134. 19 indexed citations

13.

Bergsland, Niels, Bianca Weinstock‐Guttman, Cheryl Kennedy, et al.. (2013). Subcortical Deep Gray Matter Pathology in Patients with Multiple Sclerosis Is Associated with White Matter Lesion Burden and Atrophy but Not with Cortical Atrophy: A Diffusion Tensor MRI Study. American Journal of Neuroradiology. 35(5). 912–919. 40 indexed citations

14.

Benedict, Ralph H. B., Karen Marr, Cheryl Kennedy, et al.. (2013). Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis. BMC Medicine. 11(1). 167–167. 7 indexed citations

15.

Gabelić, Tereza, Bianca Weinstock‐Guttman, Norah S. Lincoff, et al.. (2013). Retinal nerve fiber thickness and MRI white matter abnormalities in healthy relatives of multiple sclerosis patients. Clinical Neurology and Neurosurgery. 115. S49–S54. 2 indexed citations

16.

Weinstock‐Guttman, Bianca, Murali Ramanathan, Karen Marr, et al.. (2012). Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis. BMC Neurology. 12(1). 26–26. 16 indexed citations

17.

Hagemeier, Jesper, Bianca Weinstock‐Guttman, Niels Bergsland, et al.. (2012). Iron Deposition on SWI-Filtered Phase in the Subcortical Deep Gray Matter of Patients with Clinically Isolated Syndrome May Precede Structure-Specific Atrophy. American Journal of Neuroradiology. 33(8). 1596–1601. 52 indexed citations

18.

Zivadinov, Robert, Bianca Weinstock‐Guttman, Miriam Tamaño‐Blanco, et al.. (2012). Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis. Journal of Neuroimmunology. 243(1-2). 61–68. 21 indexed citations

19.

Dolić, Krešimir, Karen Marr, Michael G. Dwyer, et al.. (2011). Intra- and Extraluminal Structural and Functional Venous Anomalies in Multiple Sclerosis, as Evidenced by 2 Noninvasive Imaging Techniques. American Journal of Neuroradiology. 33(1). 16–23. 31 indexed citations

20.

Sajdel-Sulkowska, Elizabeth M., Sayeed Ur Rehman, Ronald E. Majocha, et al.. (1988). Genetic Expression of Amyloid and Glial-specific Protein in the Alzheimer Brain. Journal of the American Geriatrics Society. 36(6). 558–564. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact